CPhI South East Asia Indicates Rapid Pharma Sector Growth for the ASEAN

UBM Live

CPhI South East Asia Indicates Rapid Pharma Sector Growth for the ASEAN

AsiaNet 52769


Record numbers, a focus on development initiatives and analysis of the regional

harmonisation programme helps stimulate increased partnerships

CPhI, a division of UBM Live, announces that this year's recent CPhI South East

Asia 2013, which ran from 20-22nd March at the Jakarta International Expo in

Indonesia, was the most successful so far. The event, which is the region's go

to networking opportunity and a hot bed of pharmaceutical innovation, attracted

more than 5500 visitors from 51 countries and regions meeting over 260

exhibitors from 25 countries and regions around the world.

The strong international focus at CPhI South East Asia is representative of the

expanding pharma sector within the region and was enhanced by new co-located

events, including: PMEC for pharmaceutical machinery laboratory equipment and

analytical technology; and InnoPack South East Asia for innovative packaging

and drug delivery solutions.

"The pharma market in South East Asia is experiencing a very dynamic period

with growth of both domestic manufacturing and international trade. We

therefore designed CPhI South East Asia 2013 to reflect these sweeping changes

and ran a series of high level conferences alongside the exhibition enabling

participants to hear the latest thinking on pressing issues, including: the

impending ASEAN harmonisation due in 2015; cross-border trade and regulatory

arbitrage; IPR protection; and perspectives on the pharmerging markets,

regional consumer trends, the growth of generics and regional manufacturing,"

commented Martin Wilson, UBM Live Brand Director.

A crucial element of the ASEAN region's development, which is predicted to

reach a market value of US$80 billion by 2017, will be the establishing of

close regional partnerships and cross-sharing of information between companies.

CPhI South East Asia recognised this evolving landscape and is the only

dedicated event for the region where ideas and business opportunities can be

exchanged. Furthermore, local Governments have lent their support to the event

as they aim to implement initiatives for increased domestic production

particularly focussed on generics and a tighter regulatory landscape aimed at

reducing anti-counterfeiting issues. Coupled with a growing economic affluence

and cross border trade means the region is at the precipice of an explosion of


The increase in exhibitors, internationally credible speakers and visitors

highlights the immense strides countries here have made in manufacturing

standards, increased commitment to standardised regulation, improved packaging

technologies, and legislation protecting intellectual property - crucial to

safeguarding innovation - and improving safety standards.

Martin added: "CPhI as a whole is mirroring changes in South East Asia and our

aim is to help facilitate the adoption of new technologies and partnerships

needed to help meet the Government backed demands of an increasing standardised

regulatory arena and greater domestic production of pharmaceuticals. With a

rapidly reforming healthcare landscape this event will continue to grow next

year and help build the region as a manufacturing base and source of biotech

and pharmaceutical innovation."

CPhI South East Asia will return to the Jakarta International Expo from 20-22nd

May 2014 and UBM Live looks forward to bringing its international pharma event

back to one of the world's most dynamically evolving regions.


The UBM Live annual schedule of Pharmaceutical events also includes CPhI, ICSE,

P-MEC, BioPh and Pharmatec Japan (24-26 April, 2013 at the Tokyo Big Sight

Exhibition Centre in Japan); CPhI, P-MEC, ICSE, InnoPack and BioPh China (25-27

June, 2013 at the SNIEC in Shanghai, China); CPhI, ICSE and BioPh South America

(06-08 August, 2013 at the Expo Center Norte in Sao Paulo, Brazil); CPhI

Worldwide, ICSE, P-MEC Europe and InnoPack (22-24 October, 2012 at Messe

Frankfurt, Germany); and CPhI and P-MEC India (03-05 December, 2013 at the

Bombay Exhibition Centre in Mumbai).

Notes to the editor

About CPhI

CPhI drives growth and innovation at every step of the global pharmaceutical

supply chain from drug discovery to finished dosage. Through exhibitions,

conferences and online communities, CPhI brings together more than 100,000

pharmaceutical professionals each year to network, identify business

opportunities and expand the global market. CPhI hosts events in Europe, China,

India, Japan, Southeast Asia, Russia and South America and co-locates with ICSE

for contract services, P-MEC for machinery, equipment & technology, InnoPack

for pharmaceutical packaging and BioPh for biopharma. CPhI provides an online

buyer & supplier directory at CPhI-Online.com and hosts a global community with

news and analysis at PharmaEvolution.com, produced by UBM Live and partners.

For more information visit: http://www.cphi.com

About UBM Live

UBM Live connects people and creates opportunities for companies across five

continents to develop new business, meet customers, launch new products,

promote their brands, and expand their market. Through premier brands such as

TFM&A, Internet World, IFSEC, MD&M, CPhI, Cruise Shipping Miami, the Concrete

Show, and many others, UBM Live exhibitions, conferences, awards programs,

publications, Websites, and training and certification programs are an integral

part of the marketing plans of companies across more than 20 industry sectors.

For media enquiries, please contact:

Alex Heeley or Tristan Jervis

De Facto Communications

T: +44-207-203-6745 E: a.heeley@defacto.com  t.jervis@defacto.com